John Castellani: New drugs give hope to 3 million Americans with hepatitis C.
He says breakthrough similar to what retroviral drugs did for HIV/AIDS patients.
Castellani: Critics say drugs' high price will raise health care costs, but that's short-term.
He says drug will make costly health care interventions, like liver transplants, unnecessary.
